Induction of the Staphylococcal Proteolytic Cascade by Antimicrobial Fatty Acids in Community Acquired Methicillin Resistant Staphylococcus aureus

PLoS ONE

Volumn 7, Issue 9, 2012, Pages

  Arsic, Benjamin ^a   Zhu, Yue ^a   Heinrichs, David E ^a   McGavin, Martin J ^a  

^a UNIVERSITY OF WESTERN ONTARIO   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

BACTERIAL ENZYME; LINOLEIC ACID; PALMITIC ACID; PROTEIN SSPA; PROTEIN SSPB; SAPIENIC ACID; STEARIC ACID; UNCLASSIFIED DRUG; UNSATURATED FATTY ACID;

ARTICLE; BACTERIAL GROWTH; BACTERIAL PHENOMENA AND FUNCTIONS; BACTERIAL STRAIN; BACTERIAL VIRULENCE; BACTERIUM CULTURE; COMMUNICABLE DISEASE; CONCENTRATION RESPONSE; CONTROLLED STUDY; ENZYME INDUCTION; ENZYME RELEASE; GENETIC VARIABILITY; HOST PATHOGEN INTERACTION; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS INFECTION; NONHUMAN; OPERON; PLASMID; PROTEIN DEGRADATION; PROTEIN EXPRESSION; STAPHYLOCOCCAL PROTEOLYTIC CASCADE;

ANTI-BACTERIAL AGENTS; BACTERIAL PROTEINS; FATTY ACIDS, UNSATURATED; GENE EXPRESSION REGULATION, BACTERIAL; HOST-PATHOGEN INTERACTIONS; HUMANS; METHICILLIN-RESISTANT STAPHYLOCOCCUS AUREUS; PROTEOLYSIS; SKIN; STAPHYLOCOCCAL SKIN INFECTIONS; VIRULENCE FACTORS;

METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; STAPHYLOCOCCUS AUREUS;

EID: 84866723093     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0045952     Document Type: Article

References (86)

1. Peacock SJ, de Silva I, Lowy FD, (2001) What determines nasal carriage of Staphylococcus aureus? Trends Microbiol 9: 605-610.
2. Archer GL, (1998) Staphylococcus aureus: a well-armed pathogen. Clin Infect Dis 26: 1179-1181.
3. Lowy FD, (1998) Staphylococcus aureus infections. N Engl J Med 339: 520-532.
4. Mertz D, Frei R, Jaussi B, Tietz A, Stebler C, et al. (2007) Throat swabs are necessary to reliably detect carriers of Staphylococcus aureus. Clin Infect Dis 45: 475-477.
5. Clarke SR, Mohamed R, Bian L, Routh AF, Kokai-Kun JF, et al. (2007) The Staphylococcus aureus surface protein IsdA mediates resistance to innate defenses of human skin. Cell Host Microbe 1: 199-212.
6. Cole AM, Tahk S, Oren A, Yoshioka D, Kim YH, et al. (2001) Determinants of Staphylococcus aureus nasal carriage. Clin Diagn Lab Immunol 8: 1064-1069.
7. Fowler VG Jr, Nelson CL, McIntyre LM, Kreiswirth BN, Monk A, et al. (2007) Potential associations between hematogenous complications and bacterial genotype in Staphylococcus aureus infection. J Infect Dis 196: 738-747.
8. Holtfreter S, Nguyen TT, Wertheim H, Steil L, Kusch H, et al. (2009) Human immune proteome in experimental colonization with Staphylococcus aureus. Clin Vaccine Immunol 16: 1607-1614.
9. Kuehnert MJ, Kruszon-Moran D, Hill HA, McQuillan G, McAllister SK, et al. (2006) Prevalence of Staphylococcus aureus nasal colonization in the United States, 2001-2002. J Infect Dis 193: 172-179.
10. Pynnonen M, Stephenson RE, Schwartz K, Hernandez M, Boles BR, (2011) Hemoglobin promotes Staphylococcus aureus nasal colonization. PLoS Pathog 7: e1002104.
11. Roche FM, Meehan M, Foster TJ, (2003) The Staphylococcus aureus surface protein SasG and its homologues promote bacterial adherence to human desquamated nasal epithelial cells. Microbiology 149: 2759-2767.
12. Sivaraman K, Venkataraman N, Tsai J, Dewell S, Cole AM, (2008) Genome sequencing and analysis reveals possible determinants of Staphylococcus aureus nasal carriage. BMC Genomics 9: 433.
13. Enright MC, Robinson DA, Randle G, Feil EJ, Grundmann H, et al. (2002) The evolutionary history of methicillin-resistant Staphylococcus aureus (MRSA). Proc Natl Acad Sci U S A 99: 7687-7692.
14. Hiramatsu K, Cui L, Kuroda M, Ito T, (2001) The emergence and evolution of methicillin-resistant Staphylococcus aureus. Trends Microbiol 9: 486-493.
15. Oliveira DC, Tomasz A, de Lencastre H, (2002) Secrets of success of a human pathogen: molecular evolution of pandemic clones of meticillin-resistant Staphylococcus aureus. Lancet Infect Dis 2: 180-189.
16. Robinson DA, Enright MC, (2003) Evolutionary models of the emergence of methicillin-resistant Staphylococcus aureus. Antimicrob Agents Chemother 47: 3926-3934.
17. Deleo FR, Otto M, Kreiswirth BN, Chambers HF, (2010) Community-associated meticillin-resistant Staphylococcus aureus. Lancet 375: 1557-1568.
18. Otto M, (2010) Basis of virulence in community-associated methicillin-resistant Staphylococcus aureus. Annu Rev Microbiol 64: 143-162.
19. Moran GJ, Krishnadasan A, Gorwitz RJ, Fosheim GE, McDougal LK, et al. (2006) Methicillin-resistant S. aureus infections among patients in the emergency department. N Engl J Med 355: 666-674.
20. Elie-Turenne MC, Fernandes H, Mediavilla JR, Rosenthal M, Mathema B, et al. (2010) Prevalence and characteristics of Staphylococcus aureus colonization among healthcare professionals in an urban teaching hospital. Infect Control Hosp Epidemiol 31: 574-580.
21. Miller LG, Eells SJ, Taylor AR, David MZ, Ortiz N, et al. (2012) Staphylococcus aureus colonization among household contacts of patients with skin infections: Risk factors, strain discordance, and complex ecology. Clin Infect Dis. 54: 1523-1535.
22. Joshi GS, Spontak JS, Klapper DG, Richardson AR, (2011) Arginine catabolic mobile element encoded speG abrogates the unique hypersensitivity of Staphylococcus aureus to exogenous polyamines. Mol Microbiol 82: 9-20.
23. Diep BA, Gill SR, Chang RF, Phan TH, Chen JH, et al. (2006) Complete genome sequence of USA300, an epidemic clone of community-acquired meticillin-resistant Staphylococcus aureus. Lancet 367: 731-739.
24. Diep BA, Stone GG, Basuino L, Graber CJ, Miller A, et al. (2008) The arginine catabolic mobile element and staphylococcal chromosomal cassette mec linkage: convergence of virulence and resistance in the USA300 clone of methicillin-resistant Staphylococcus aureus. J Infect Dis 197: 1523-1530.
25. Montgomery CP, Boyle-Vavra S, Daum RS, (2009) The arginine catabolic mobile element is not associated with enhanced virulence in experimental invasive disease caused by the community-associated methicillin-resistant Staphylococcus aureus USA300 genetic background. Infect Immun 77: 2650-2656.
26. Miller SJ, Aly R, Shinefeld HR, Elias PM, (1988) In vitro and in vivo antistaphylococcal activity of human stratum corneum lipids. Arch Dermatol 124: 209-215.
27. Wille JJ, Kydonieus A, (2003) Palmitoleic acid isomer (C16:1delta6) in human skin sebum is effective against gram-positive bacteria. Skin Pharmacol Appl Skin Physiol 16: 176-187.
28. Stefaniak AB, Harvey CJ, (2006) Dissolution of materials in artificial skin surface film liquids. Toxicol In Vitro 20: 1265-1283.
29. Takigawa H, Nakagawa H, Kuzukawa M, Mori H, Imokawa G, (2005) Deficient production of hexadecenoic acid in the skin is associated in part with the vulnerability of atopic dermatitis patients to colonization by Staphylococcus aureus. Dermatology 211: 240-248.
30. Do TQ, Moshkani S, Castillo P, Anunta S, Pogosyan A, et al. (2008) Lipids including cholesteryl linoleate and cholesteryl arachidonate contribute to the inherent antibacterial activity of human nasal fluid. J Immunol 181: 4177-4187.
31. Shryock TR, Kapral FA, (1992) The production of bactericidal fatty acids from glycerides in staphylococcal abscesses. J Med Microbiol 36: 288-292.
32. Malachowa N, Whitney AR, Kobayashi SD, Sturdevant DE, Kennedy AD, et al. (2011) Global changes in Staphylococcus aureus gene expression in human blood. PLoS One 6: e18617.
33. Palazzolo-Ballance AM, Reniere ML, Braughton KR, Sturdevant DE, Otto M, et al. (2008) Neutrophil microbicides induce a pathogen survival response in community-associated methicillin-resistant Staphylococcus aureus. J Immunol 180: 500-509.
34. Massimi I, Park E, Rice K, Muller-Esterl W, Sauder D, et al. (2002) Identification of a novel maturation mechanism and restricted substrate specificity for the SspB cysteine protease of Staphylococcus aureus. J Biol Chem 277: 41770-41777.
35. Nickerson N, Ip J, Passos DT, McGavin MJ, (2010) Comparison of Staphopain A (ScpA) and B (SspB) precursor activation mechanisms reveals unique secretion kinetics of proSspB (Staphopain B), and a different interaction with its cognate Staphostatin, SspC. Mol Microbiol 75: 161-177.
36. Nickerson NN, Joag V, McGavin MJ, (2008) Rapid autocatalytic activation of the M4 metalloprotease aureolysin is controlled by a conserved N-terminal fungalysin-thermolysin-propeptide domain. Mol Microbiol. 69: 1530-1543.
37. Nickerson NN, Prasad L, Jacob L, Delbaere LT, McGavin MJ, (2007) Activation of the SspA serine protease zymogen of Staphylococcus aureus proceeds through unique variations of a trypsinogen-like mechanism and is dependent on both autocatalytic and metalloprotease-specific processing. J Biol Chem 282: 34129-34138.
38. Rice K, Peralta R, Bast D, de Azavedo J, McGavin MJ, (2001) Description of staphylococcus serine protease (ssp) operon in Staphylococcus aureus and nonpolar inactivation of sspA-encoded serine protease. Infect Immun 69: 159-169.
39. Kennedy AD, Porcella SF, Martens C, Whitney AR, Braughton KR, et al. (2010) Complete nucleotide sequence analysis of plasmids in strains of Staphylococcus aureus clone USA300 reveals a high level of identity among isolates with closely related core genome sequences. J Clin Microbiol 48: 4504-4511.
40. Zielinska AK, Beenken KE, Joo HS, Mrak LN, Griffin LM, et al. (2011) Defining the strain-dependent impact of the Staphylococcal accessory regulator (sarA) on the alpha-toxin phenotype of Staphylococcus aureus. J Bacteriol 193: 2948-2958.
41. Arnaud M, Chastanet A, Debarbouille M, (2004) New vector for efficient allelic replacement in naturally nontransformable, low-GC-content, gram-positive bacteria. Appl Environ Microbiol 70: 6887-6891.
42. Novick RP, (1991) Genetic systems in staphylococci. Methods Enzymol 204: 587-636.
43. Gyenis L, Duncan JS, Turowec JP, Bretner M, Litchfield DW, (2011) Unbiased functional proteomics strategy for protein kinase inhibitor validation and identification of bona fide protein kinase substrates: application to identification of as a substrate for CK2. J Proteome Res 10: 4887-4901.
44. Kenny JG, Ward D, Josefsson E, Jonsson IM, Hinds J, et al. (2009) The Staphylococcus aureus response to unsaturated long chain free fatty acids: survival mechanisms and virulence implications. PLoS One 4: e4344.
45. Parsons JB, Frank MW, Subramanian C, Saenkham P, Rock CO, (2011) Metabolic basis for the differential susceptibility of Gram-positive pathogens to fatty acid synthesis inhibitors. Proc Natl Acad Sci U S A 108: 15378-15383.
46. Drake DR, Brogden KA, Dawson DV, Wertz PW, (2008) Thematic review series: skin lipids. Antimicrobial lipids at the skin surface. J Lipid Res 49: 4-11.
47. Ayora S, Lindgren PE, Gotz F, (1994) Biochemical properties of a novel metalloprotease from Staphylococcus hyicus subsp. hyicus involved in extracellular lipase processing. J Bacteriol 176: 3218-3223.
48. McAleese FM, Walsh EJ, Sieprawska M, Potempa J, Foster TJ, (2001) Loss of clumping factor B fibrinogen binding activity by Staphylococcus aureus involves cessation of transcription, shedding and cleavage by metalloprotease. J Biol Chem 276: 29969-29978.
49. Geiger T, Goerke C, Mainiero M, Kraus D, Wolz C, (2008) The virulence regulator Sae of Staphylococcus aureus: promoter activities and response to phagocytosis-related signals. J Bacteriol 190: 3419-3428.
50. DeLeo FR, Kennedy AD, Chen L, Bubeck Wardenburg J, Kobayashi SD, et al. (2011) Molecular differentiation of historic phage-type 80/81 and contemporary epidemic Staphylococcus aureus. Proc Natl Acad Sci U S A 108: 18091-18096.
51. McAdam PR, Templeton KE, Edwards GF, Holden MT, Feil EJ, et al. (2012) Molecular tracing of the emergence, adaptation, and transmission of hospital-associated methicillin-resistant Staphylococcus aureus. Proc Natl Acad Sci U S A 109: 9107-9112.
52. McGavin MJ, Arsic B, Nickerson NN (2012) Evolutionary blueprint for host- and niche-adaptation in Staphylococcus aureus clonal complex CC30. Frontiers in Cellular and Infection Microbiology 2.
53. Laarman AJ, Ruyken M, Malone CL, van Strijp JA, Horswill AR, et al. (2011) Staphylococcus aureus metalloprotease aureolysin cleaves complement C3 to mediate immune evasion. J Immunol 186: 6445-6453.
54. Sieprawska-Lupa M, Mydel P, Krawczyk K, Wojcik K, Puklo M, et al. (2004) Degradation of human antimicrobial peptide LL-37 by Staphylococcus aureus-derived proteinases. Antimicrob Agents Chemother 48: 4673-4679.
55. Gonzalez DJ, Okumura CY, Hollands A, Kersten R, Akong-Moore K, et al. (2012) Novel phenol-soluble modulin derivatives in community-associated methicillin-resistant Staphylococcus aureus identified through imaging mass spectrometry. J Biol Chem 287: 13889-13898.
56. McGavin MJ, Zahradka C, Rice K, Scott JE, (1997) Modification of the Staphylococcus aureus fibronectin binding phenotype by V8 protease. Infect Immun 65: 2621-2628.
57. Beaufort N, Wojciechowski P, Sommerhoff CP, Szmyd G, Dubin G, et al. (2008) The human fibrinolytic system is a target for the staphylococcal metalloprotease aureolysin. Biochem J 410: 157-165.
58. Imamura T, Tanase S, Szmyd G, Kozik A, Travis J, et al. (2005) Induction of vascular leakage through release of bradykinin and a novel kinin by cysteine proteinases from Staphylococcus aureus. J Exp Med 201: 1669-1676.
59. Greenway DL, Dyke KG, (1979) Mechanism of the inhibitory action of linoleic acid on the growth of Staphylococcus aureus. J Gen Microbiol 115: 233-245.
60. Beenken KE, Mrak LN, Griffin LM, Zielinska AK, Shaw LN, et al. (2010) Epistatic relationships between sarA and agr in Staphylococcus aureus biofilm formation. PLoS One 5: e10790.
61. Boles BR, Horswill AR, (2008) Agr-mediated dispersal of Staphylococcus aureus biofilms. PLoS Pathog 4: e1000052.
62. Kies S, Otto M, Vuong C, Gotz F, (2001) Identification of the sigB operon in Staphylococcus epidermidis: construction and characterization of a sigB deletion mutant. Infect Immun 69: 7933-7936.
63. Iwase T, Uehara Y, Shinji H, Tajima A, Seo H, et al. (2010) Staphylococcus epidermidis Esp inhibits Staphylococcus aureus biofilm formation and nasal colonization. Nature 465: 346-349.
64. Boles BR, Horswill AR, (2011) Staphylococcal biofilm disassembly. Trends Microbiol 19: 449-455.
65. Joo HS, Cheung GY, Otto M, (2011) Antimicrobial activity of community-associated methicillin-resistant Staphylococcus aureus is caused by phenol-soluble modulin derivatives. J Biol Chem 286: 8933-8940.
66. Lai Y, Villaruz AE, Li M, Cha DJ, Sturdevant DE, et al. (2007) The human anionic antimicrobial peptide dermcidin induces proteolytic defence mechanisms in staphylococci. Mol Microbiol 63: 497-506.
67. Li M, Cha DJ, Lai Y, Villaruz AE, Sturdevant DE, et al. (2007) The antimicrobial peptide-sensing system aps of Staphylococcus aureus. Mol Microbiol 66: 1136-1147.
68. Li M, Lai Y, Villaruz AE, Cha DJ, Sturdevant DE, et al. (2007) Gram-positive three-component antimicrobial peptide-sensing system. Proc Natl Acad Sci U S A 104: 9469-9474.
69. Howden BP, Stinear TP, Allen DL, Johnson PD, Ward PB, et al. (2008) Genomic analysis reveals a point mutation in the two-component sensor gene graS that leads to intermediate vancomycin resistance in clinical Staphylococcus aureus. Antimicrob Agents Chemother 52: 3755-3762.
70. Meehl M, Herbert S, Gotz F, Cheung A, (2007) Interaction of the GraRS two-component system with the VraFG ABC transporter to support vancomycin-intermediate resistance in Staphylococcus aureus. Antimicrob Agents Chemother 51: 2679-2689.
71. Ohbayashi T, Irie A, Murakami Y, Nowak M, Potempa J, et al. (2011) Degradation of fibrinogen and collagen by staphopains, cysteine proteases released from Staphylococcus aureus. Microbiology 157: 786-792.
72. Voyich JM, Vuong C, DeWald M, Nygaard TK, Kocianova S, et al. (2009) The SaeR/S gene regulatory system is essential for innate immune evasion by Staphylococcus aureus. J Infect Dis 199: 1698-1706.
73. Cheng AG, DeDent AC, Schneewind O, Missiakas D, (2011) A play in four acts: Staphylococcus aureus abscess formation. Trends Microbiol 19: 225-232.
74. Cheng AG, Kim HK, Burts ML, Krausz T, Schneewind O, et al. (2009) Genetic requirements for Staphylococcus aureus abscess formation and persistence in host tissues. FASEB J 23: 3393-3404.
75. Holden MT, Feil EJ, Lindsay JA, Peacock SJ, Day NP, et al. (2004) Complete genomes of two clinical Staphylococcus aureus strains: evidence for the rapid evolution of virulence and drug resistance. Proc Natl Acad Sci U S A 101: 9786-9791.
76. McAdam PR, Templeton KE, Edwards GF, Holden MT, Feil EJ, et al. (2012) Molecular tracing of the emergence, adaptation, and transmission of hospital-associated methicillin-resistant Staphylococcus aureus. Proc Natl Acad Sci U S A. 109: 9107-9112.
77. Burlak C, Hammer CH, Robinson MA, Whitney AR, McGavin MJ, et al. (2007) Global analysis of community-associated methicillin-resistant Staphylococcus aureus exoproteins reveals molecules produced in vitro and during infection. Cell Microbiol 9: 1172-1190.
78. Miller LG, Perdreau-Remington F, Rieg G, Mehdi S, Perlroth J, et al. (2005) Necrotizing fasciitis caused by community-associated methicillin-resistant Staphylococcus aureus in Los Angeles. N Engl J Med 352: 1445-1453.
79. Baba T, Takeuchi F, Kuroda M, Yuzawa H, Aoki K, et al. (2002) Genome and virulence determinants of high virulence community-acquired MRSA. Lancet 359: 1819-1827.
80. Baba T, Bae T, Schneewind O, Takeuchi F, Hiramatsu K, (2008) Genome sequence of Staphylococcus aureus strain Newman and comparative analysis of staphylococcal genomes: polymorphism and evolution of two major pathogenicity islands. J Bacteriol 190: 300-310.
81. Duthie ES, Lorenz LL, (1952) Staphylococcal coagulase; mode of action and antigenicity. J Gen Microbiol 6: 95-107.
82. Robinson DA, Kearns AM, Holmes A, Morrison D, Grundmann H, et al. (2005) Re-emergence of early pandemic Staphylococcus aureus as a community-acquired meticillin-resistant clone. Lancet 365: 1256-1258.
83. Moore PC, Lindsay JA, (2002) Molecular characterisation of the dominant UK methicillin-resistant Staphylococcus aureus strains, EMRSA-15 and EMRSA-16. J Med Microbiol 51: 516-521.
84. Gillaspy AF, Hickmon SG, Skinner RA, Thomas JR, Nelson CL, et al. (1995) Role of the accessory gene regulator (agr) in pathogenesis of staphylococcal osteomyelitis. Infect Immun 63: 3373-3380.
85. Yeung M, Balma-Mena A, Shear N, Simor A, Pope E, et al. (2011) Identification of major clonal complexes and toxin producing strains among Staphylococcus aureus associated with atopic dermatitis. Microbes Infect 13: 189-197.
86. Guerout-Fleury AM, Shazand K, Frandsen N, Stragier P, (1995) Antibiotic-resistance cassettes for Bacillus subtilis. Gene 167: 335-336.